Adherence to Fish Oil Intervention in Patients With Chronic Kidney Disease

Journal of Renal Nutrition

Volumn 20, Issue 5, 2010, Pages 329-333

  Zabel, Rachel ^a   Ash, Susan ^a   King, Neil ^a   Bauer, Judith ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b WESLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FISH OIL; ICOSAPENTAENOIC ACID;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; FEASIBILITY STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RENAL REPLACEMENT THERAPY; SELF REPORT; STATISTICS;

BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FEASIBILITY STUDIES; FEMALE; FISH OILS; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RENAL DIALYSIS; SELF REPORT;

EID: 77955814200     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.01.003     Document Type: Article

References (10)

1. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008, 73:391-398.
2. Hamazaki T., Nakazawa R., Tateno S., et al. Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients. Kidney Int 1984, 26:81-84.
3. Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract 1990, 40:114-116.
4. Zabel R., Ash S., Bauer J., King N. The effect of fish oil on novel inflammatory markers in hemodialysis patients. J Ren Nutr 2008, 18(Suppl):S26.
5. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
6. Fearon K.C.H., Von Meyenfeldt M.F., Moses A.G.W., et al. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomised double blind trial. Gut 2003, 52:1479-1486.
7. Cleland L.G., Proudman S.M., Hall C., et al. A biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids 2003, 38:419-424.
8. Friedman A., Moe S., Perkins S., Li Y., Watkins B. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis 2006, 47:1064-1071.
9. Saran R., Bragg-Gresham J., Rayner H., et al. Nonadherence in hemodialysis: Associations with mortality, hospitalisations and practice patterns in the DOPPS. Kidney Int 2003, 64:254-262.
10. Bame S., Petersen N., Wray N. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med 1993, 37:1035-1043.